143 related articles for article (PubMed ID: 2753395)
1. Early treatment with deferoxamine limits myocardial ischemic/reperfusion injury.
Reddy BR; Kloner RA; Przyklenk K
Free Radic Biol Med; 1989; 7(1):45-52. PubMed ID: 2753395
[TBL] [Abstract][Full Text] [Related]
2. Deferoxamine pretreatment reduces canine infarct size and oxidative injury.
Lesnefsky EJ; Repine JE; Horwitz LD
J Pharmacol Exp Ther; 1990 Jun; 253(3):1103-9. PubMed ID: 2359019
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment with the iron chelator desferrioxamine fails to provide sustained protection against myocardial ischaemia-reperfusion injury.
Reddy BR; Wynne J; Kloner RA; Przyklenk K
Cardiovasc Res; 1991 Sep; 25(9):711-8. PubMed ID: 1799904
[TBL] [Abstract][Full Text] [Related]
4. "Reperfusion injury" by oxygen-derived free radicals? Effect of superoxide dismutase plus catalase, given at the time of reperfusion, on myocardial infarct size, contractile function, coronary microvasculature, and regional myocardial blood flow.
Przyklenk K; Kloner RA
Circ Res; 1989 Jan; 64(1):86-96. PubMed ID: 2909304
[TBL] [Abstract][Full Text] [Related]
5. Coronary venous retroinfusion of deferoxamine reduces infarct size in pigs.
Kobayashi S; Tadokoro H; Wakida Y; Kar S; Nordlander R; Haendchen RV; Corday E
J Am Coll Cardiol; 1991 Aug; 18(2):621-7. PubMed ID: 1856431
[TBL] [Abstract][Full Text] [Related]
6. Myocardial protection in the occlusion/reperfusion dog model: the role of ischemic necrosis vs reperfusion injury.
Chagas AC; Pileggi F; Lopes EA; Da-Luz PL
Braz J Med Biol Res; 1995 Sep; 28(9):951-9. PubMed ID: 8580882
[TBL] [Abstract][Full Text] [Related]
7. Effect of oxygen-derived free radical scavengers on infarct size following six hours of permanent coronary artery occlusion: salvage or delay of myocyte necrosis?
Przyklenk K; Kloner RA
Basic Res Cardiol; 1987; 82(2):146-58. PubMed ID: 3606542
[TBL] [Abstract][Full Text] [Related]
8. High-dose iron-chelator therapy during reperfusion with deferoxamine-hydroxyethyl starch conjugate fails to reduce canine infarct size.
Lesnefsky EJ; Hedlund BE; Hallaway PE; Horwitz LD
J Cardiovasc Pharmacol; 1990 Oct; 16(4):523-8. PubMed ID: 1706792
[TBL] [Abstract][Full Text] [Related]
9. Effects of hydroxyethyl starch conjugated deferoxamine on myocardial functional recovery following coronary occlusion and reperfusion in dogs.
Maruyama M; Pieper GM; Kalyanaraman B; Hallaway PE; Hedlund BE; Gross GJ
J Cardiovasc Pharmacol; 1991 Jan; 17(1):166-75. PubMed ID: 1708051
[TBL] [Abstract][Full Text] [Related]
10. Improvement of postischemic myocardial function and metabolism induced by administration of deferoxamine at the time of reflow: the role of iron in the pathogenesis of reperfusion injury.
Ambrosio G; Zweier JL; Jacobus WE; Weisfeldt ML; Flaherty JT
Circulation; 1987 Oct; 76(4):906-15. PubMed ID: 2820615
[TBL] [Abstract][Full Text] [Related]
11. Evidence for a role of iron-catalyzed oxidants in functional and metabolic stunning in the canine heart.
Farber NE; Vercellotti GM; Jacob HS; Pieper GM; Gross GJ
Circ Res; 1988 Aug; 63(2):351-60. PubMed ID: 3396156
[TBL] [Abstract][Full Text] [Related]
12. Does preconditioning protect the coronary vasculature from subsequent ischemia/reperfusion injury?
Bauer B; Simkhovich BZ; Kloner RA; Przyklenk K
Circulation; 1993 Aug; 88(2):659-72. PubMed ID: 8339428
[TBL] [Abstract][Full Text] [Related]
13. Effect of superoxide dismutase on myocardial infarct size in the canine heart after 6 hours of regional ischemia and reperfusion: a demonstration of myocardial salvage.
Chi LG; Tamura Y; Hoff PT; Macha M; Gallagher KP; Schork MA; Lucchesi BR
Circ Res; 1989 Apr; 64(4):665-75. PubMed ID: 2702730
[TBL] [Abstract][Full Text] [Related]
14. Effect of intracoronary diltiazem on infarct size and regional myocardial function in the ischemic reperfused canine heart.
Higginson L; Tang A; Knoll G; Calvin J
J Am Coll Cardiol; 1991 Sep; 18(3):868-75. PubMed ID: 1869751
[TBL] [Abstract][Full Text] [Related]
15. Coronary vascular injury following transient coronary artery occlusion: prevention by pretreatment with deferoxamine, dimethylthiourea and N-2-mercaptoproprionyl glycine.
Patterson E
J Pharmacol Exp Ther; 1993 Sep; 266(3):1528-35. PubMed ID: 8371155
[TBL] [Abstract][Full Text] [Related]
16. Iron-mediated radical reactions upon reperfusion contribute to myocardial "stunning".
Bolli R; Patel BS; Jeroudi MO; Li XY; Triana JF; Lai EK; McCay PB
Am J Physiol; 1990 Dec; 259(6 Pt 2):H1901-11. PubMed ID: 2260714
[TBL] [Abstract][Full Text] [Related]
17. The iron chelator desferrioxamine attenuates postischemic ventricular dysfunction.
Bolli R; Patel BS; Zhu WX; O'Neill PG; Hartley CJ; Charlat ML; Roberts R
Am J Physiol; 1987 Dec; 253(6 Pt 2):H1372-80. PubMed ID: 3425739
[TBL] [Abstract][Full Text] [Related]
18. Reduction of myocardial reperfusion injury by intravenous adenosine administered during the early reperfusion period.
Pitarys CJ; Virmani R; Vildibill HD; Jackson EK; Forman MB
Circulation; 1991 Jan; 83(1):237-47. PubMed ID: 1984882
[TBL] [Abstract][Full Text] [Related]
19. Role of oxygen-derived free radicals in canine reperfusion arrhythmias.
Euler DE
Am J Physiol; 1995 Jan; 268(1 Pt 2):H295-300. PubMed ID: 7840275
[TBL] [Abstract][Full Text] [Related]
20. Failure of superoxide dismutase to limit size of myocardial infarction after 40 minutes of ischemia and 4 days of reperfusion in dogs.
Uraizee A; Reimer KA; Murry CE; Jennings RB
Circulation; 1987 Jun; 75(6):1237-48. PubMed ID: 3568330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
